Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy

P Chelladurai, O Boucherat, K Stenmark… - British journal of …, 2021 - Wiley Online Library
Epigenetic mechanisms, including DNA methylation and histone post‐translational
modifications (PTMs), have been known to regulate chromatin structure and lineage‐specific …

DNA methylation and histone modification in hypertension

S Stoll, C Wang, H Qiu - International journal of molecular sciences, 2018 - mdpi.com
Systemic hypertension, which eventually results in heart failure, renal failure or stroke, is a
common chronic human disorder that particularly affects elders. Although many signaling …

Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension

P Chelladurai, C Kuenne, A Bourgeois… - Science Translational …, 2022 - science.org
Phenotypic alterations in resident vascular cells contribute to the vascular remodeling
process in diseases such as pulmonary (arterial) hypertension [P (A) H]. How the molecular …

Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

J Dave, V Jagana, R Janostiak, M Bisserier - Journal of Translational …, 2023 - Springer
Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the
remodeling of pulmonary blood vessels. If left unaddressed, PAH can lead to right heart …

FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension

A Bourgeois, C Lambert, K Habbout… - Journal of Molecular …, 2018 - Springer
Pulmonary arterial hypertension (PAH) is a progressive vascular remodeling disease
characterized by a persistent elevation of pulmonary artery pressure, leading to right heart …

Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension

Y Jiang, S Song, J Liu, L Zhang, X Guo, J Lu… - Frontiers in …, 2023 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a severe progressive disease that may cause early
right ventricular failure and eventual cardiac failure. The pathogenesis of PAH involves …

Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs

KR Zahid, U Raza, J Chen, UJ Raj… - Cardiovascular …, 2020 - academic.oup.com
Pulmonary arterial hypertension (PAH) is a disease with complex pathobiology, significant
morbidity and mortality, and remains without a cure. It is characterized by vascular …

MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways

Z Cai, J Li, Q Zhuang, X Zhang, A Yuan… - … & molecular medicine, 2018 - nature.com
Pulmonary vascular remodeling due to excessive proliferation and resistance to apoptosis of
pulmonary artery smooth muscle cells (PASMCs) is the hallmark feature of pulmonary …

MicroRNA and lncRNA as the future of pulmonary arterial hypertension treatment

Ł Wołowiec, M Mędlewska, J Osiak… - International Journal of …, 2023 - mdpi.com
Pulmonary hypertension (PH) is characterized by a progressive increase in pulmonary
arterial pressure and pulmonary vascular resistance. In a short time, it leads to right …

Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled

AR Hemnes, M Humbert - European Respiratory Review, 2017 - Eur Respiratory Soc
The pathobiology of pulmonary arterial hypertension (PAH) is complex and incompletely
understood. Although three pathogenic pathways have been relatively well characterised, it …